Lipocine Inc. (LPCN)

2.87
NASDAQ : Health Technology
Prev Close 2.90
Day Low/High 2.77 / 2.97
52 Wk Low/High 1.04 / 3.45
Avg Volume 148.00K
Exchange NASDAQ
Shares Outstanding 24.84M
Market Cap 72.05M
EPS -0.60
P/E Ratio N/A
Div & Yield N.A. (N.A)

Noteworthy Wednesday Option Activity: LPCN, WWAV, TNDM

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in Lipocine Inc , where a total of 1,421 contracts have traded so far, representing approximately 142,100 underlying shares. That amounts to about 72.9% of LPCN's average daily trading volume over the past month of 195,020 shares.

These 5 Stocks Under $10 Could Make You a Lot of Money

These 5 Stocks Under $10 Could Make You a Lot of Money

Here's a technical look at how to trade several under-$10 stocks triggering breakout trades.

Lipocine Stock Sees Short Interest Decline 17.8%

Lipocine Stock Sees Short Interest Decline 17.8%

The most recent short interest data has been released for the 09/30/2016 settlement date, which shows a 424,331 share decrease in total short interest for Lipocine Inc , to 1,955,453, a decrease of 17.83% since 09/15/2016. Total short interest is just one way to look at short data; another metric that we here at Dividend Channel find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares traded.

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors In Lipocine Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of August 30, 2016

INVESTOR ALERT: Levi & Korsinsky, LLP Reminds Investors In Lipocine Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of August 30, 2016

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Lipocine Inc.

GPM Reminds Investors Of The August 30th Deadline In The Class Action Lawsuit Against Lipocine Inc. And Encourages Investors To Contact The Firm

GPM Reminds Investors Of The August 30th Deadline In The Class Action Lawsuit Against Lipocine Inc. And Encourages Investors To Contact The Firm

Glancy Prongay & Murray LLP ("GPM") reminds investors of the August 30, 2016 deadline to file a lead plaintiff motion in the class action filed on behalf of a class (the "Class") of investors who purchased...

SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Lawsuit Involving Lipocine Inc. And A Lead Plaintiff Deadline Of August 30, 2016

SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Reminds Investors Of A Class Action Lawsuit Involving Lipocine Inc. And A Lead Plaintiff Deadline Of August 30, 2016

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Lipocine Inc.

Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investors With Losses From Investment In Lipocine Inc. To Contact The Firm

Brower Piven Alerts Shareholders Of Approaching Deadline In Class Action Lawsuit And Encourages Investors With Losses From Investment In Lipocine Inc. To Contact The Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of...

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors In Lipocine Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of August 30, 2016

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors In Lipocine Inc. Of A Class Action Lawsuit And A Lead Plaintiff Deadline Of August 30, 2016

The following statement is being issued by Levi & Korsinsky, LLP: To: All persons or entities who purchased or otherwise acquired securities of Lipocine Inc.

SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of Class Action Lawsuit Involving Lipocine Inc. And A Lead Plaintiff Deadline Of August 30, 2016

SHAREHOLDER ALERT: The Law Offices Of Vincent Wong Notifies Investors Of Class Action Lawsuit Involving Lipocine Inc. And A Lead Plaintiff Deadline Of August 30, 2016

The Law Offices of Vincent Wong announce that a class action lawsuit has been commenced in the USDC for the District of New Jersey on behalf of investors who purchased Lipocine Inc.

Trade These 5 Biotech Breakouts Now for Big Gains

Trade These 5 Biotech Breakouts Now for Big Gains

Here's a technical look at how to trade five biotech stocks that are setting up to break out and trade much higher.

Cohen Milstein Sellers & Toll PLLC Announces The Investigation Of Lipocine, Inc.

Cohen Milstein Sellers & Toll PLLC Announces The Investigation Of Lipocine, Inc.

Cohen Milstein Sellers & Toll PLLC is conducting an investigation to determine whether Lipocine, Inc.

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Lipocine Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

INVESTOR ALERT: Brower Piven Encourages Shareholders Who Have Losses In Excess Of $100,000 From Investment In Lipocine Inc. To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the District of New Jersey on behalf of...

SHAREHOLDER NOTICE: Rosen Law Firm Reminds Lipocine Inc. Investors Of Important Deadline In Class Action Filed By Firm - LPCN

SHAREHOLDER NOTICE: Rosen Law Firm Reminds Lipocine Inc. Investors Of Important Deadline In Class Action Filed By Firm - LPCN

Rosen Law Firm, a global investor rights law firm, reminds purchasers of Lipocine Inc.

IMPORTANT INVESTOR NOTICE: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Lipocine Inc. And Reminds Investors With Losses To Contact The Firm

IMPORTANT INVESTOR NOTICE: Khang & Khang LLP Announces The Filing Of A Securities Class Action Lawsuit Against Lipocine Inc. And Reminds Investors With Losses To Contact The Firm

Khang & Khang LLP (the "Firm") announces that a class action lawsuit has been filed against Lipocine Inc.

INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Lipocine Inc. And Reminds Investors With Losses To Contact The Firm

INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit Against Lipocine Inc. And Reminds Investors With Losses To Contact The Firm

Lundin Law PC announces a class action lawsuit has been filed against Lipocine Inc.